Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy

類似資料

• Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients
  著者:: Gianotti, Nicola, 等
  出版事項: (2017)
• Unboosted atazanavir with lamivudine/emtricitabine for patients with long-lasting virological suppression
  著者:: Carbone, Alessia, 等
  出版事項: (2014)
• Predictors of lack of serological response to syphilis treatment in HIV-infected subjects
  著者:: Spagnuolo, Vincenzo, 等
  出版事項: (2014)
• Incidence and Predictors of Serological Treatment Response in Early and Late Syphilis Among People Living With HIV
  著者:: Spagnuolo, Vincenzo, 等
  出版事項: (2018)
• A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study
  著者:: Spagnuolo, Vincenzo, 等
  出版事項: (2019)